Liver fibrosis staging: F0 to F4
Fibrosis staging turns a vague risk into a clearer management pathway. Here is what the stages mean and how non-invasive tests support them.
What F0 to F4 means
Fibrosis staging describes scarring in the liver, from F0 (no fibrosis) to F4 (cirrhosis). Clinical urgency rises sharply toward F3 and F4, where surveillance and specialist management become more important.
How elastography supports staging
Elastography does not replace clinical judgement. It gives a rapid estimate of stiffness that can be repeated over time and combined with laboratory markers. See kPa to stage tables and understanding your results.
Why advanced fibrosis is the turning point
The difference between mild and advanced fibrosis is practical, not academic. Once people enter F3–F4 territory, hepatocellular carcinoma surveillance, portal hypertension assessment, and management intensity often change.
Monitoring and reversibility
Fibrosis can improve with effective treatment and metabolic improvement. That is why serial non-invasive testing is often more useful than a single snapshot. See improving your score.
Frequently asked questions
Is F4 always symptomatic cirrhosis?
No. Someone can have compensated cirrhosis without obvious symptoms. That is why earlier staging and surveillance pathways matter.
Can fibrosis improve over time?
Yes. Depending on cause and treatment response, fibrosis can regress. Repeatable non-invasive monitoring is useful when the question is trend rather than a one-off result.
Does one kPa number equal one stage for everyone?
No. Cut-offs vary by disease cause and clinical context. Your clinician interprets stiffness alongside blood tests and history.